• ATP Workflows for TCAIM–OGDH Metabolism Studies

  2026-08-31

  Use ATP as both a controlled energy-state perturbation and a functional readout when studying TCAIM-mediated OGDH regulation. This workflow separates direct mitochondrial enzyme effects from ATP-dependent chaperone behavior, improving interpretation across biochemical and cell-based assays.

• Omeprazole A2845: Protocol and QC Guide

  2026-08-30

  Omeprazole (SKU A2845) provides a defined H+,K+-ATPase inhibitor for controlled gastric acid secretion research, antiulcer activity studies, and related in vitro or ex vivo workflows. This guide addresses dissolution, controls, storage, and assay interpretation; the material is for scientific research only and is not a diagnostic or medical product.

• TCEP hydrochloride: Reliable Assay Reductant

  2026-08-29

  Learn how Tris(2-carboxyethyl) phosphine hydrochloride (TCEP hydrochloride), SKU B6055, can help laboratories control disulfide-dependent chemistry, redox interference, and reagent-handling variability in cell-based and biochemical workflows. This scenario-driven guide emphasizes compatibility testing, practical preparation, data interpretation, and evidence-based product selection.

• Isobavachalcone Triggers Apoptosis and Pyroptosis in ATC

  2026-08-28

  The reference study shows that isobavachalcone suppresses anaplastic thyroid carcinoma through cell-cycle arrest and concurrent activation of apoptosis and pyroptosis. Its central mechanistic contribution is linking caspase-dependent cleavage of PARP and GSDME, suggesting that one protease axis can produce distinct but simultaneous tumor-cell death programs.

• ABT-888 (Veliparib): From PARP Biology to Translation

  2026-08-28

  ABT-888 (Veliparib) offers translational researchers a selective PARP1/2 inhibition platform for studying DNA repair inhibition, chemotherapy and radiation sensitization, and biomarker-defined resistance. This thought-leadership analysis connects colorectal cancer and microsatellite instability models with emerging replication-stress biology in PARP-resistant ovarian cancer, while emphasizing experimental rigor and preclinical boundaries.

• Microlipophagy and SCLC Radioresistance

  2026-08-27

  A 2026 study identifies microlipophagy-driven lipid droplet remodeling as a metabolic adaptation associated with radioresistant small-cell lung cancer. By combining imaging, lipid measurements, autophagy inhibition, and transcriptomics, the work suggests that disrupting autophagy may restore radiation sensitivity, although the findings remain preclinical.

• ATP Solution (100 mM) for Molecular Assays

  2026-08-27

  ATP Solution (100 mM) is a ready-to-use Adenosine-5'-triphosphate reagent for kinase, transcription, ligation, and phosphorylation workflows. The K1043 formulation combines 100 mM ATP, near-neutral pH, ≥99% HPLC purity, and stated nuclease/phosphatase control for reproducible molecular biology assays.

• Spatial Proteomics of Antimicrobial Neural Probes

  2026-08-26

  This 2026 Journal of Materials Chemistry B study presents titania nanotube arrays as antimicrobial, therapeutic-releasing interfaces for intracortical microelectrodes. By applying spatial proteomics to tissue surrounding implanted probes, the authors examine local neuronal integrity, immune activation, cytokine expression, and coating-side requirements relevant to chronic neuroinflammation.

• Idoxuridine: Designing Mechanistic Antiviral Assays

  2026-08-26

  Idoxuridine, also known as 5-iodo-2'-deoxyuridine, can be used to connect viral DNA synthesis disruption with interpretable assay outcomes. This article develops a mechanism-centered workflow inspired by human-cell pharmacology while clearly separating established antiviral evidence from cross-domain experimental lessons.

• Vidarabine monohydrate: Antiviral Workflow Guide

  2026-08-25

  Vidarabine monohydrate supports controlled studies of viral DNA synthesis, replication kinetics, and nucleoside analog behavior when stock preparation and vehicle controls are handled carefully. This practical guide translates its DMSO-based formulation profile into cell-based antiviral workflows, assay controls, and troubleshooting strategies.

• c-Myc Tag Peptide: A Smarter Assay Control

  2026-08-25

  The c-Myc Peptide is more than an epitope competitor: it is a practical specificity control for interpreting antibody-based measurements of tagged proteins. This article connects c-Myc tag peptide competition with transcription-factor regulation, assay design, and lessons from selective IRF3 autophagy research.

• A40926 Regulation in Nonomuraea

  2026-08-24

  Yushchuk et al. developed promoter-probe tools and a regulator-based strategy to improve A40926 production in the genetically challenging genus Nonomuraea. Their results connect promoter activity, pathway-specific regulation, and bioreactor-scale productivity, providing a rational alternative to less targeted strain improvement.

• Poly(I:C) as a Causal Probe of Cell Injury

  2026-08-24

  Poly (I:C), a synthetic double-stranded RNA analog, is more than an interferon inducer: it can function as a controlled perturbation for separating innate immune signaling from cell-death responses. This article connects TLR3 biology with practical assay design and the context-dependent framework of liver injury research.

• Berbamine hydrochloride for NF-κB Assays

  2026-08-23

  Berbamine hydrochloride supports mechanism-focused cancer research spanning NF-κB pathway interrogation, leukemia assays, and ferroptosis studies in HCC models. This workflow-led guide connects practical assay design with the METTL16-SENP3-LTF findings while distinguishing established product information from hypothesis-generating applications.

• AIBP–LRP2 Axis Restricts Collateral Vessel Growth

  2026-08-22

  Zhu et al. identify an AIBP–LRP2–HDL–miR-223 pathway that suppresses CXCR4-positive, stemlike capillary endothelial cells during collateral vessel formation. The work supports a two-phase model in which expanding capillary cells later acquire arterial characteristics, suggesting a mechanistic route for improving revascularization after ischemic injury.

8204 records 1/547 page Next 12345 下5页 Last page